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Abstract
Introduction Histological examination of lung specimens from
patients with pneumonia shows the presence of desquamated
pneumocytes and erythrophages. We hypothesized that these
modifications should also be present in bronchoalveolar lavage
fluid (BAL) from patients with hospital-acquired pneumonia.
Methods We conducted a prospective study in mechanically
ventilated patients with clinical suspicion of pneumonia. Patients
were classified as having hospital-acquired pneumonia or not, in
accordance with the quantitative microbiological cultures of
respiratory tract specimens. A group of severe community-
acquired pneumonias requiring mechanical ventilation during
the same period was used for comparison. A specimen of BAL
(20 ml) was taken for cytological analysis. A semiquantitative
analysis of the dominant leukocyte population, the presence of
erythrophages/siderophages and desquamated type II
pneumocytes was performed.
Results In patients with confirmed hospital-acquired
pneumonia, we found that 13 out of 39 patients (33.3%) had
erythrophages/siderophages in BAL, 18 (46.2%) had
desquamated pneumocytes and 8 (20.5%) fulfilled both criteria.
Among the patients with community-acquired pneumonia, 7 out
of 15 (46.7%) had erythrophages/siderophages and 6 (40%)
had desquamated pneumocytes on BAL cytology. Only four
(26.7%) fulfilled both criteria. No patient without hospital-
acquired pneumonia had erythrophages/siderophages and only
3 out of 18 (16.7%) had desquamated pneumocytes on BAL
cytology.
Conclusion Cytological analysis of BAL from patients with
pneumonia (either community-acquired or hospital-acquired)
shows elements of cytological alveolar damage as hemorrhage
and desquamated type II pneumocytes much more frequently
than in BAL from patients without pneumonia. These elements
had a high specificity for an infectious cause of pulmonary
infiltrates but low specificity. These lesions could serve as an
adjunct to diagnosis in patients suspected of having ventilator-
associated pneumonia.
BAL = bronchoalveolar lavage fluid; CAP = community-acquired pneumonia; FiO2 = fraction of inspired oxygen; ICU = intensive care unit; PaO2 = 
partial arterial oxygen tension; PTC = protected telescopic catheters; SAPS = Simplified Acute Physiology Score; VAP = ventilator-associated 
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Introduction
Pneumonia is a common problem in critical care patients. Ven-
tilator-associated pneumonia (VAP) complicates the course of
as much as 27% of patients requiring mechanical ventilation
[1,2]. Because mortality in patients with pneumonia is high and
clinical studies have shown that an adequate antimicrobial
treatment improves outcome, it is mandatory to identify
infected patients precisely and give them effective treatment
[3].
Unfortunately, at present there are no consensus criteria for
the diagnosis of VAP [1,2]. Although clinical criteria (purulent
tracheal secretions, fever), combined with the presence of
new or worsening infiltrates on a chest radiogram or leukocy-
tosis, are sensitive, they have poor specificity for diagnosing
VAP [4]. Using solely clinical criteria entails a high risk of dis-
pensing unnecessary antimicrobial treatment with the risk of
emergence of multidrug-resistant organisms [5]. So far no bio-
logical test has proven useful in differentiating patients with
and without pneumonia, despite very promising candidates
[6]. Most diagnostic strategies rely today on quantitative cul-
tures of samples of bronchial secretions from distal airways
such as protected specimen brush, bronchoalveolar lavage
fluid (BAL) or protected telescopic catheters (PTC) performed
either under fibro-bronchoscopic guidance or in a blind man-
ner. Even though there is still controversy over whether such
techniques should be used as diagnostic criteria or just for
guiding antibacterial treatment after diagnosis has been made,
they are extensively recommended and used in clinical prac-
tice. Contrasting with the large amount of information about
the quantitative culture of bronchial specimens, little has been
published on the cytological aspects of BAL in pneumonia.
Previous reports emphasized the lack of specificity of neu-
trophil predominance [7]. From all cytological information that
can be gathered, so far only the presence of intracellular path-
ogens in more than 1 to 5% of BAL neutrophils has been
retained as being highly suggestive of bacterial pneumonia in
ventilated patients [8].
The lung response to local aggression after infectious pneu-
monia results in epithelial damage, edema, hemorrhage, the
intra-alveolar accumulation of polymorphonuclear neutrophils
and hyaline membrane formation. Macrophages that engulf
red blood cells take the aspect of erythrophagocytes and later
siderophages. The presence of one of these elements can be
a useful marker of active alveolar hemorrhage [9]. Furthermore,
damage at the epithelial alveolar level can lead to desquama-
tion of dystrophic pneumocytes. These cells can eventually be
found in BAL, as shown in some patients with acute lung injury
[10]. Jacobs et al. [11,12] have described the presence of
desquamated type II pneumocytes in the BAL from patients
with various types of pulmonary infection. Thus, the presence
of lesions of alveolar damage associated with alveolar hemor-
rhage and desquamated type II pneumocytes in BAL could
help to differentiate pneumonia from other causes of pulmo-
nary infiltrates (such as atelectasis or pulmonary edema) and
could be of diagnostic importance.
The aim of our study was to evaluate the incidence of these
findings in patients with severe pneumonia who were receiving
mechanical ventilation.
Materials and methods
A prospective study cohort was selected from patients hospi-
talized in our medical intensive care unit (ICU) between Janu-
ary 1999 and April 2002. Patients under mechanical
ventilation for at least 3 days were selected in accordance with
the following criteria: first, high clinical suspicion of pneumonia
based on the presence of a new or worsening infiltrate on a
supine chest X-ray, and at least two of the following: worsen-
ing pulmonary gas transfer as evaluated by the ratio of partial
arterial oxygen tension to the fraction of inspired oxygen
(PaO2/FiO2), a temperature of 38.5°C or more, purulent tra-
cheal secretions, and leukocytosis; and second, no recent
change (less than 3 days) in antimicrobial treatment. Patients
with overt left ventricular failure were not included. For all
these patients a fiber-optic bronchoscopy was performed and
distal airways were sampled with a PTC (Combicath; Plas-
timed Lab, Le Plessis Bouchard, France) and a BAL was
taken. Sampling conditions were described by Pham et al.
[13] and were compliant with recent recommendations [14].
In brief, after the adjustment of FiO2 to 95% or more and deep-
ened sedation if needed, the fiberscope was inserted (through
an adapter piece permitting continuous ventilation) avoiding
suctioning and without instilling local anesthetics.
The area of sampling was chosen on the basis of the chest
radiograph and PTC was always performed before BAL was
acquired. The volume of saline prepared for injection was 150
ml. On the basis of the results of the microbiological cultures,
the patients were classified into two categories: those with a
diagnosis of VAP in which at least one pathogen cultured at
significant concentrations on PTC (103 colony-forming units/
ml) or BAL (104 colony-forming units/ml) and those without
pneumonia with no cultured pathogen in significant amounts,
in whom no antimicrobial treatment was started. This second
group provided the control cases with a high clinical suspicion
of pneumonia but without bacteriological confirmation. Doubt-
ful cases with pathogens cultured in non-significant concen-
trations were excluded from the final analysis. In parallel we
recruited for comparative analysis a group of ventilated
patients admitted to the ICU with a diagnosis of community-
acquired pneumonia (CAP) in whom bronchoscopy with distal
sampling was performed because of severity or rapid aggrava-
tion despite antibiotic therapy started in the previous 24 hours
by their general physician or in the emergency room [15].
The ethical committee of our hospital approved the study pro-
tocol. This workup is standard in our unit and althoughAvailable online http://ccforum.com/content/10/1/R2
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Table 1
Recruited patients
Group Patients with community-acquired pneumonia Patients with hospital-acquired pneumonia (n = 57)
With pneumonia With pneumonia Without pneumoniac
Patients, n (%) 15 39 (68.4%) 18 (31.6%)
Age, years (mean ± SD) 69.0 ± 17.4 65.3 ± 15.9 62.6 ± 19.7
Male gender n (%) 8 (53.3%) 26 (66.7%) 9 (50%)
Co-morbidities, n 82 5 1 0
Cardiac failure 0 8 2
Neoplastic disease 2 5 0
AIDS 2 2 1
Chronic respiratory failure 2 2 1
Cirrhosis 2 8 6
Ventilation, days before bronchoalveolar 
lavagea (median (IQR))
1 (0–2) 8 (3–15) 3 (0–10.5)
Length of stay in ICU (median (IQR)) 4.5 (1.0–15.7) 18 (10.7–34.0) 18 (7.5–30.2)
Mortality, n (%) 12 (80%) 21 (53.8%) 10 (55.6%)
SAPS II at admission (mean ± SD) 74.45 ± 21.50 64.36 ± 20.60 60.83 ± 21.41
SAPS II at inclusion (mean ± SD) - 53.0 ± 19.4 66.0 ± 26.1
Vasoactive drugs (yes/no) 12/3 29/10 10/8
Number of failing organsb (median (IQR)) 2 (2–3) 3 (1–3) 2 (1–3)
None 0 7 2
12 6 5
28 6 3





Bilateral opacities, n (%) 7 (46.7%) 20 (51.3%) 11 (61.1%)
Multilobar involvement, n (%) 11 (73.3%) 21 (53.8%) 13 (72.2%)
Clinical variables (mean ± SD)
MAP, mmHg 68.11 ± 19.27 64.6 ± 16.6 61.55 ± 19.94
GCS before sedation 11.2 ± 5.0 9.85 ± 5.24 11.8 ± 4.9
GCS > 9 10 22 13
PaO2/FiO2, mmHg 177.91 ± 88.43 190.0 ± 63.3 195.27 ± 86.20
Creatinine, µmol/l 162.4 ± 66.4 198 ± 196 162 ± 122.2
ap = 0.027, Mann–Whitney U test between patients with and without hospital-acquired pneumonia. bSepsis-related Organ Failure Assessment 
(SOFA) score categories 3 and 4. cThe diagnoses for the 18 patients without ventilator-associated pneumonia were as follows: cardiac failure, 7 
patients; sepsis with ARDS, 6 patients; cancer, 2 patients; atelectasis due to endobronchial lesion (cancer), 1 patient; non-significant growth of 
acinetobacter 102 (and not treated), 1 patient; no definite diagnosis, 1 patient. GCS, Glasgow coma score; ICU, intensive care unit; IQR, 
interquartile range; MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; PaO2, partial arterial oxygen tension.Critical Care    Vol 10 No 1    Grigoriu et al.
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informed consent was not mandatory, it was obtained from the
patient's next-of-kin whenever possible.
Data collection
The following variables were recorded from each patient: age,
sex, Simplified Acute Physiology Score II (SAPS II) score [16]
at admission and at the time of inclusion in the protocol, car-
diac rate, arterial pressure, body temperature, Glasgow coma
score before sedation, need for inotropic drugs, number of fail-
ing organs as evaluated by grade 3 and 4 SOFA (Sepsis-
related Organ Failure Assessment) score [17], isolated micro-
organisms on quantitative microbiological cultures, time
between admission and BAL, length of mechanical ventilation,
length of stay in ICU, and status at hospital discharge.
Specimen processing
After acquisition of BAL a small sample (20 ml) was sent for
cytological analysis. PTC and the rest of the BAL were sent to
the microbiology laboratory where they were immediately
processed. For cytological analysis, slides were prepared by
cytocentrifugation with a Shandon Cytospin® 4 Cytocentri-
fuge (Thermo Electron Corporation). Stains with May Grün-
wald Giemsa, Perls, Papanicolaou, Grocott and Ziehl were
performed for each sample. The spot was examined at low and
high magnifications; the dominant cellular population (more
than 60%) and the presence of erythrophages and of desqua-
mated alveolar type II pneumocytes were reported. Even if
available, the result of the cytological examination was not
immediately made known to the clinician and was not taken
into account for patient management. The histologist was also
blinded about the final diagnosis of the patient and the deci-
sion to treat or not.
Statistical analysis
Results are reported as mean ± SD or as median and inter-
quartile range when appropriate. Statistical comparisons were
performed with Student's t test for variables with a known nor-
mal distribution. A Kruskal–Wallis test was used for multiple
group comparison; group pairs were further analyzed with a
Mann–Whitney U test. All p values were two-sided and p =
0.05 was considered significant. A Bonferroni correction was
applied for multiple comparisons.
Table 2
Pathogens isolated by culture of bronchoalveolar lavage fluid or protected telescopic catheter
Species isolated Patients with community-acquired pneumonia Patients with hospital-acquired pneumonia (n = 57)
With pneumonia (n = 15) With pneumonia (n = 39) No pneumonia (n = 18)
Streptococcus pneumoniae 42 -
Haemophilus influenzae 31 -
Legionella sp. 1 - -
Klebsiella pneumoniae 12 -
Escherichia coli 25 -
Pseudomonas aeruginosa 21 3 -
Staphylococcus aureus 19 -
Proteus sp. - 3 -
Enterobacter sp. - 2 -
Serratia sp. - 1 -
Other 2 5 -
Candida sp. - 3 6
Figure 1
Bronchoalveolar lavage: predominance of neutrophil cell population,  hemorrhage with erythrophagocytosis (black arrow) and desquamated  type II pneumocytes (white arrow) Bronchoalveolar lavage: predominance of neutrophil cell population, 
hemorrhage with erythrophagocytosis (black arrow) and desquamated 
type II pneumocytes (white arrow). Papanicolaou staining; magnification 
× 400.Available online http://ccforum.com/content/10/1/R2
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Results
A total of 57 mechanically ventilated patients with clinical sus-
picion of hospital-acquired pneumonia were recruited during
the study period. In 39 patients the diagnosis of VAP was con-
firmed and they received antibiotic treatment; in 18 patients
the diagnosis of pneumonia was excluded and no antibiotics
were started. In parallel we recruited 15 patients with severe
CAP who fitted our inclusion criteria. The general characteris-
tics of the population are described in Table 1. There were no
significant differences between the three groups except for
the delay between ICU admission and fibroscopy (p = 0.001,
Kruskal–Wallis), which was statistically significantly shorter in
patients without hospital-acquired pneumonia than in patients
with VAP, as expected because the risk of pneumonia
increases with the number of days under mechanical ventila-
tion [18]. Our group of CAP had a very high mortality (80%)
because they all required mechanical ventilation at admission,
occurred in old patients (median age 73 years), seriously ill
patients (mean SAPS II score at admission: 74.4) with a
median of two failing organs (interquartile range 2 to 3). Con-
sequently the length of stay in ICU was shorter because of a
high early mortality rate in this group.
The isolated organisms from BAL and PTC show an usual pro-
file for such infections, with a predominance of Streptococcus
pneumoniae  and  Haemophilus influenzae in patients with
CAP and Pseudomonas aeruginosa, Staphylococcus aureus
and other Gram-negative rods in patients with hospital-
acquired pneumonia (Table 2). The three Candida species
isolated in patients with hospital-acquired pneumonia as well
as the six isolated in patients without pneumonia were not con-
sidered to reflect active infection.
Cytological analysis
The typical lesions observed are presented in Figure 1. In the
pattern of cytological abnormalities we observed a predomi-
nance of neutrophil cell population in patients with pneumonia
in most cases. However, as already reported [8], this element
could not distinguish between patients with pneumonia and
those without pneumonia because it was also present in about
half of the latter group (Table 3).
Interestingly, the presence of erythrophagocytosis was noted
only in patients with pneumonia, either hospital-acquired (13
out of 39 (33.3%)) or community-acquired (7 out of 15
(46.7%)). No such elements could be found in patients with-
out pneumonia. Desquamated pneumocytes were observed
much more frequently in patients with pneumonia (6 out of 15
(40%) in patients with CAP and 18 out of 39 (46.2%) in those
with VAP) compared with ventilated patients without pneumo-
nia (3 out of 18 (16.7%)). These two combined criteria were
observed in 26.7% of patients with CAP and 20.5% of
patients with hospital-acquired pneumonia (Table 3).
The estimated specificity and positive predictive values of the
presence of erythrophagocytes alone or combined with the
presence of desquamated pneumocytes are very high in our
series (virtually 100% because there were no false positive
cases). The sensitivity and negative predictive values are low
(22.2% and 30%, respectively, for the whole group of all 54
patients with pneumonia). Calculated likelihood positive ratios
were very high, stressing the possibility that such criteria could
be used as an adjunct for a positive diagnosis (Table 4), thus
helping to differentiate true infection from simple colonization.
Discussion
Hospital-acquired pneumonia is a frequent and severe compli-
cation occurring in patients under mechanical ventilation.
Rapid identification of such patients and accurate treatment
selection are important goals for the clinician. Clinical criteria
alone are not reliable enough to be used for diagnosis, result-
ing in unnecessary treatment. Moreover, bacterial colonization
is frequently encountered, and it is often difficult to distinguish
simple colonization from true infection. At present there are no
consensual diagnostic criteria for VAP. Most strategies are
actually based on a quantitative culture of samples from distal
airways retrieved by BAL, protected specimen brush or PTC.
The results of these cultures are available only after 48 hours.
Thus quicker diagnostic criteria have been sought. So far only
the presence of intracellular pathogens and more recently a
high titer of soluble TREMs (triggering receptors expressed on
myeloid cells) have been proven to be useful in diagnostic
Table 3
Cytological analysis of bronchoalveolar lavage fluid
Cell type Patients with community-acquired pneumonia Patients with hospital-acquired pneumonia (n = 57)
With pneumonia (n = 15) pa With pneumonia (n = 39) No pneumonia (n = 18) pb
Neutrophil predominance (%) 15 (100.0%) 0.274 36 (92.3%) 8 (44.4%) 0.001
Erythrophagocytes 7 (46.7%) 0.368 13 (33.3%) 0 0.006
Type II pneumocytes 6 (40.0%) 0.686 18 (46.2%) 3 (16.7%) 0.03
Erythrophagocytes and type II 
pneumocytes
4 (26.7%) 0.629 8 (20.5%) 0 0.04
aMann–Whitney test for comparison between community-acquired and hospital-acquired pneumonias. bMann–Whitney test for comparison 
between patients with and without hospital-acquired pneumonia.Critical Care    Vol 10 No 1    Grigoriu et al.
Page 6 of 7
(page number not for citation purposes)
workup [6]. However, cytological analysis can provide other
data of potential use as diagnostic criteria.
We show here that cytological lesions of alveolar damage
expressed as the presence of hemorrhage and desquamated
type II pneumocytes in BAL can be found in patients with
severe pneumonia, either hospital-acquired or community-
acquired. These findings occur much more frequently in
patients with pneumonia than in those with other pathologies
mimicking pneumonia. Our study was performed on a sample
of patients admitted to the ICU with a high clinical suspicion of
hospital-acquired pneumonia. This series consisted of very
severely ill patients as shown by the high SAPS II score at
admission, the number of failing organs and the high mortality.
This sample may not be representative for all patients with
VAP. However, because the pathological lesions of pneumo-
nia should be similar whatever the severity of the disease, it is
probable that similar lesions are to be found in all patients with
pneumonia.
Another important point concerns the diagnostic approach
used in our series. Our main goal in this descriptive study was
to obtain a homogeneous sample of patients. We therefore
selected very robust criteria for diagnosis, with the risk of
excluding some patients with definitive pneumonia [14].
Because we excluded patients with recent changes in antibi-
otic therapy, these criteria are known to have an acceptable
sensitivity and a good specificity for the diagnosis of VAP
[19,20]. However, we cannot exclude the possibility that in
some rare cases a misclassification that could result in
reduced differences between groups.
A point worthy of discussion concerns the methodology of
BAL and cytology examination. Actual recommendations sug-
gest that volumes for BAL should be at least 120 ml [1] or 140
ml [14]. We did not monitor recovered volumes but used an
instillation volume of 150 ml for our study, which is at the lower
end of recommended values. If larger volumes were used it is
possible that this could add to the sensitivity of the technique
and reveal lesions of alveolar damage in more patients. Results
are also highly dependent on accurate selection of the sam-
pling area. It is possible that the large number of false negative
cases in our series could be due to inaccurate selection of the
sample area or low BAL volume.
However, the accuracy of cytological examination is depend-
ent on the experience of the cytologist, which influences both
the sensitivity and the specificity. This difficulty can be
enhanced by the fact that there are no existing strict diagnostic
criteria for such lesions. Nevertheless, all specimens were
examined by the same team during the whole study. As a result
the same diagnostic criteria were applied to all patients and
reading was done blinded to the clinical characteristics of the
patients, so it is improbable that significant reader-dependent
bias occurred during the pathological examination.
Another potential bias could be introduced by the prolonged
duration of the study. Long observational studies are subject
to biases in recruitment criteria and to changes in diagnostic
and therapeutic strategies. The monocentric nature of the
study and the fact that it was necessary to include a sufficient
number of patients imposed the duration of the study. How-
ever, using the same stringent criteria for selecting and classi-
fying cases minimized potential biases.
An important point concerns the potential utility of the tech-
nique. Because these lesions are found combined only in
about 20% of patients with pneumonia, their utility as a diag-
nostic criterion is confined to a subgroup of patients. Moreo-
ver, lesions of alveolar damage and therefore cytological
alveolar damage have no specificity and can be found in vari-
ous types of pulmonary injury, such as those induced by chem-
ical agents or bacteria or even occur secondary to endothelial
damage. However, the strong positive predictive value and the
rapid availability of the results make them useful as an aid to
the diagnostic decision and may help to differentiate infection
from colonization. However, this implies that an 'on call'
cytopathologist should be available at all times. It also should
be noted that such lesions are found in some patients with
acute lung injury irrespective of the presence of a pulmonary
infection [10]. Our series included patients with severe pneu-
monia, bilateral infiltrates and very low PaO2/FiO2, and we
show that these lesions were rarely found in patients without
pneumonia. Therefore such criteria should be used with
caution in patients with acute lung injury or acute respiratory
distress syndrome, in whom more evaluation is needed.
Table 4
Operational characteristics of studied criteria for the diagnosis of pneumonia
Criterion All patients Patients with hospital-acquired pneumonia
Se Sp PPV NPV Se Sp PPV NPV
Presence of type II pneumocytes 0.444 0.833 0.889 0.333 0.462 0.833 0.857 0.417
Presence of erythrophagocytes 0.370 1.000 1.000 0.346 0.333 1.000 1.000 0.409
Both criteria 0.222 1.000 1.000 0.300 0.205 1.000 1.000 0.367
NPV, negative predictive value; PPV, positive predictive value; Se, sensitivity; Sp, specificity.Available online http://ccforum.com/content/10/1/R2
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Conclusion
We showed that lesions of cytological alveolar damage are
found in patients with severe hospital-acquired pneumonia
and severe CAP much more frequently than in patients without
pneumonia. Such lesions have a similar incidence in patients
with severe CAP and VAP, confirming the robustness of our
data. These findings may help in deciding whether isolated
bacteria are the result of true infection. To the best of our
knowledge similar data have not been published previously,
except one report that showed a higher prevalence of reactive
type II pneumocytes in patients with VAP [21]. However, the
poor sensitivity and the necessity for a trained pathologist lim-
its the potential utility of the technique. More prospective clin-
ical evaluation is necessary before making recommendations
for day-to-day practice.
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Key messages
• Cytological  alveolar  damage reflects active processes 
involving damage to alveolar epithelium.
•  Although these lesions had no specificity in themselves, 
they can be found in both hospital-acquired pneumonia 
and CAP more frequently than arising from non-infec-
tious causes of pulmonary infiltrates.
•  These lesions could help to distinguish between coloni-
zation and true infection in patients suspected for VAP.